Annovis Bio, Inc. (ANVS)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 01:18PM EDT. Market open.
| Previous close | 6.03 |
| Open | 6.13 |
| Bid | 5.82 x 900 |
| Ask | 5.83 x 800 |
| Day's range | 5.40 - 6.35 |
| 52-week range | 4.79 - 22.49 |
| Volume | |
| Avg. volume | 493,703 |
| Market cap | 63.925M |
| Beta (5Y monthly) | 1.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
Amicus (FOLD) reports first-quarter 2024 results, wherein earnings beat the Zacks Consensus Estimate but sales miss the same. The company updates its financial guidance for 2024.
- Zacks
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
Xenon (XENE) reports better-than-expected first-quarter 2024 earnings. Its development programs for azetukalner in epilepsy and MDD are progressing well.
- Zacks
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Catalyst (CPRX) reports first-quarter results, wherein earnings and revenues beat the Zacks Consensus Estimate, driven by strong Firdapse sales.
© 2024 Yahoo. All rights reserved.